<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03732729</url>
  </required_header>
  <id_info>
    <org_study_id>2018-1204</org_study_id>
    <nct_id>NCT03732729</nct_id>
  </id_info>
  <brief_title>Clinical Effect of Massage Chair on Older Adults</brief_title>
  <acronym>SEAT</acronym>
  <official_title>A Study for Evaluation of Massage Chair in Community-dwelling Older Adults: Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eunju Lee</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bodyfriend</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Asan Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The use of massage chairs is becoming more popular in many countries. According to the&#xD;
      previous reports, some manual massages have positive effects on the mood, pain, fatigue, and&#xD;
      sleep quality. However, the clinical benefits of the massage chair have not been fully&#xD;
      understood. In this trial, it is aimed to evaluate the clinical effectiveness of the 6-month&#xD;
      regular use of massage chair twice a day. It is hypothesized that long-term regular use of&#xD;
      massage chair has positive effects on the hormonal level related to the stress, inflammation,&#xD;
      and aging, as well as physical, psychologic, and muscle quality.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of enrolled 80 patients after randomization(1:1) in intervention(Massage chair)group&#xD;
      and Control groups, will be provided&#xD;
&#xD;
        -  Massage chair group&#xD;
&#xD;
             -  lifestyle modification education + using massage chair twice per day during 24weeks&#xD;
&#xD;
        -  control group: only lifestyle modification education&#xD;
&#xD;
             1. Screening visit&#xD;
&#xD;
                  -  collection demographic data, BMD, vital sign, Medication history&#xD;
&#xD;
             2. Visit 1 (0-week)&#xD;
&#xD;
                  1. Vital sign&#xD;
&#xD;
                  2. Charlson comorbidity index&#xD;
&#xD;
                  3. Laboratory test&#xD;
&#xD;
                       -  WBC diff count, Hb, creatinine, ALT, albumin, hsCRP, ESR cortisol,&#xD;
                          serotonin, DHEA-s, IGF-1, NK cell, Telomere length&#xD;
&#xD;
                  4. Questionnaire: K-MMSE, SGDS-K, BEPSI-K, EQ-5D-5L&#xD;
&#xD;
                  5. Physical&amp; muscular assessment&#xD;
&#xD;
                       -  SPPB, Grip strength, Muscle tone, Bioimpedance analysis&#xD;
&#xD;
             3. Visit 2-6 (4,8,12,16 weeks) via Phone contact: assess compliance and adverse events&#xD;
&#xD;
             4. visit 7 (24weeks)&#xD;
&#xD;
                  1. Vital sign&#xD;
&#xD;
                  2. Laboratory test&#xD;
&#xD;
                       -  WBC diff count, Hb, creatinine, ALT, albumin, hsCRP, ESR cortisol,&#xD;
                          serotonin, DHEA-s, IGF-1, NK cell, Telomere length&#xD;
&#xD;
                  3. Questionnaire: K-MMSE, SGDS-K, BEPSI-K, EQ-5D-5L&#xD;
&#xD;
                  4. Physical&amp; muscular assessment&#xD;
&#xD;
                       -  SPPB, Grip strength, Muscle tone, Bioimpedance analysis&#xD;
&#xD;
                  5. Compliance&#xD;
&#xD;
                  6. Adverse events&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 11, 2018</start_date>
  <completion_date type="Actual">April 16, 2020</completion_date>
  <primary_completion_date type="Actual">April 16, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum cortisol level</measure>
    <time_frame>Change from baseline serum cortisol level at 24weeks</time_frame>
    <description>Investigate serum cortisol level of baseline &amp; 24weeks between 2 groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cortisol/DHEA-s ratio</measure>
    <time_frame>Change from Baseline cortisol/DHEA-s ratio level at 24weeks</time_frame>
    <description>Investigate serum Cortisol/DHEA-s ratio level of baseline &amp; 24weeks between 2 groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Serotonin level</measure>
    <time_frame>Change from Baseline serum serotonin level at 24weeks</time_frame>
    <description>Investigate serum serotonin level of baseline &amp; 24weeks between 2 groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum IGF-1 level</measure>
    <time_frame>Change from Baseline Serum IGF-1 level level at 24weeks</time_frame>
    <description>Investigate serum IGF-1 level of baseline &amp; 24weeks between 2 groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ESR</measure>
    <time_frame>Change from Baseline ESR level at 24weeks</time_frame>
    <description>Investigate serum ESR level of baseline &amp; 24weeks between 2 groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hsCRP</measure>
    <time_frame>Change from Baseline hs CRP level at 24weeks</time_frame>
    <description>Investigate serum hsCRP level of baseline &amp; 24weeks between 2 groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NK cell activity</measure>
    <time_frame>Change from Baseline NK cell activity level at 24weeks</time_frame>
    <description>Investigate serum NK cell activity of baseline &amp; 24weeks between 2 groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Telomere length</measure>
    <time_frame>Change from Baseline Telomere length level at 24weeks</time_frame>
    <description>Investigate Telomere length of baseline &amp; 24weeks between 2 groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Korean version Short form Geriatric Depression Scale(SGDS-K) score</measure>
    <time_frame>SGDS-K summed total score is changed lower at 24weeks from baseline</time_frame>
    <description>15 item measure to assess the depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Korean version -Brief Encounter Psychosocial Instrument(BEPSI-K) score</measure>
    <time_frame>BEPSI-K summed total score is changed lower at 24weeks from baseline</time_frame>
    <description>5 item measure to assess the Stress</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The 5-level EQ-5D version(EQ-5D-5L) score</measure>
    <time_frame>EQ-5D-5L summed total score is changed higher at 24weeks from baseline</time_frame>
    <description>6 item measure to assess the quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle tone score</measure>
    <time_frame>Individual site Muscle tone score is changed higher at 24weeks from baseline</time_frame>
    <description>6 item measure to assess Muscle tone of both trapezoid&amp; forearm &amp; thigh</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Older Adults</condition>
  <arm_group>
    <arm_group_label>Massage chair</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>lifestyle modification education(once)+ Using massage chair</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>lifestyle modification education(once)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>massage chair</intervention_name>
    <description>Patient should use massage chair, twice per day, for 30minutes</description>
    <arm_group_label>Massage chair</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Community-dwelling healthy adults between 50-75 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Unable to sign his/her own informed consent&#xD;
&#xD;
          2. Any disability or damages in 4 extremity.&#xD;
&#xD;
          3. Who have exercised regularly more than twice a week during the last 24 weeks&#xD;
&#xD;
          4. Who have received regular massage during the last 24 weeks&#xD;
&#xD;
          5. Confirmed osteoporosis of T score &lt;-2.5 from BMD or history of compression fracture&#xD;
&#xD;
          6. Cortisol-metabolism disorders or other diseases that can affect steroid secretion&#xD;
&#xD;
          7. Who have taken any medication related with steroid secretion or metabolism within 2&#xD;
             weeks&#xD;
&#xD;
          8. Expected life expectancy less than 12 months (Symptomatic heart failure, end-stage&#xD;
             renal failure)&#xD;
&#xD;
          9. Spouse is already enrolled in this research&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eunju Lee</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asan Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>AsanMC</name>
      <address>
        <city>Seoul</city>
        <zip>05505</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>November 4, 2018</study_first_submitted>
  <study_first_submitted_qc>November 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 7, 2018</study_first_posted>
  <last_update_submitted>July 25, 2020</last_update_submitted>
  <last_update_submitted_qc>July 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Asan Medical Center</investigator_affiliation>
    <investigator_full_name>Eunju Lee</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

